Topical Photodynamic Therapy Induces Systemic Immunosuppression via Generation of Platelet-Activating Factor Receptor Ligands
- 1 January 2015
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 135 (1), 321-323
- https://doi.org/10.1038/jid.2014.313
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor ReceptorMediators of Inflammation, 2012
- Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A PhotosensitivityJournal of Biological Chemistry, 2012
- The immunosuppressive side of PDTPublished by Springer Science and Business Media LLC ,2011
- Topical photodynamic therapy is immunosuppressive in humansBritish Journal of Dermatology, 2009
- Ultraviolet B Radiation Generated Platelet-Activating Factor Receptor Agonist Formation Involves EGF-R-Mediated Reactive Oxygen SpeciesPublished by The American Association of Immunologists ,2009
- Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effectsProstaglandins & Other Lipid Mediators, 2008
- Guidelines for topical photodynamic therapy: updateBritish Journal of Dermatology, 2008
- UVB Radiation-Mediated Inhibition of Contact Hypersensitivity Reactions Is Dependent on the Platelet-Activating Factor SystemJournal of Investigative Dermatology, 2008
- Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acidThe Journal of Dermatology, 2007
- Platelet-Activating Factor Is Crucial in Psoralen and Ultraviolet A-Induced Immune Suppression, Inflammation, and ApoptosisThe American Journal of Pathology, 2006